New inhaler could ease agonizing mouth sores for cancer patients
NCT ID NCT07327216
Summary
This study is testing whether a medication called Sapylin, inhaled as a mist, works as well as the standard steroid dexamethasone to prevent and reduce severe mouth sores caused by combined chemotherapy and radiation for nasopharyngeal cancer. Researchers will enroll 180 patients to see if Sapylin helps patients complete their full cancer treatment by managing this painful side effect. The goal is to find a safe, effective way to improve quality of life during treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, China
Conditions
Explore the condition pages connected to this study.